| Nov 4 |
Should Weakness in CSL Limited's (ASX:CSL) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
|
| Oct 18 |
New Data Presented at IDWeek 2024 Show Adjuvanted and High-Dose Influenza Vaccines are Comparable in Protecting Adults 65 Years of Age and Older Against Seasonal Influenza
|
| Oct 17 |
Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy
|
| Oct 17 |
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
|
| Oct 16 |
CSL Seqirus Presents Data at IDWeek 2024 Highlighting the Urgent Need to Increase Influenza Vaccination Rates and the Benefits of Cell-Based Influenza Vaccines
|
| Oct 4 |
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
|
| Oct 4 |
CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Sixth BARDA Award in Response to Avian Influenza
|
| Oct 4 |
Sanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply
|
| Oct 2 |
EXEL vs. CSLLY: Which Stock Is the Better Value Option?
|
| Oct 1 |
CSL Seqirus Presents Real-World Evidence at OPTIONS XII Conference Highlighting Effectiveness of Influenza Vaccinations
|
